Gene · 6041
Papers3,466
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,466
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Beyond Viral Restriction: The Metabolic Dimensions of Interferon-Stimulated Genes in Antiviral Immunity. | Viruses | 2026 | 41754503 | PubTator, text mining | PubMed |
| Protease Inhibitors and Innate Immune Agonists as Antiviral Strategies Against Dengue and Zika Viruses. | Pathogens | 2026 | 41754484 | PubTator, text mining | PubMed |
| High-Throughput Sequencing Decodes tsRNA Landscapes: Insights into Cancer Biomarkers and Therapeutic Targets. | Int J Mol Sci | 2026 | 41752084 | PubTator, text mining | PubMed |
| Genetic, Sociodemographic and Clinical Determinants of COVID-19 Severity in the Republic of Srpska: Exploring Potential Links with Neanderthal-Derived Variants. | Biomedicines | 2026 | 41751377 | PubTator, text mining | PubMed |
| The Impact of Genetics on Pediatric Interstitial Lung Diseases: A Narrative Literature Review and Clinical Implications. | Biomedicines | 2026 | 41751284 | PubTator, text mining | PubMed |
| Research Progress and Applications of the Rotavirus Reverse Genetics System. | Animals (Basel) | 2026 | 41751070 | PubTator, text mining | PubMed |
| Targeted Protein Degradation in Cancer: PROTACs, New Targets, and Clinical Mechanisms. | Biomolecules | 2026 | 41750393 | PubTator, text mining | PubMed |
| Stalled translation on transcripts cleaved by RNase L activates signaling important for innate immunity. | RNA | 2026 | 41748288 | PubTator, text mining | PubMed |
| Cytoplasmic mRNA decay by the antiviral nuclease RNase L promotes transcriptional repression. | Cell Rep | 2026 | 41746807 | PubTator, text mining | PubMed |
| ADAR1: a central regulator of dsRNA sensing in host-virus interactions. | Front Immunol | 2026 | 41743727 | PubTator, text mining | PubMed |
| Immune Microenvironment of Hair Follicles in Tumor Immunotherapy. | Immunotargets Ther | 2026 | 41737273 | PubTator, text mining | PubMed |
| Antiviral drug discovery and development: challenges and future directions. | Signal Transduct Target Ther | 2026 | 41735249 | PubTator, text mining | PubMed |
| Serum proteomic characterization of stump-tailed macaques (Macaca arctoides) with neutralizing antibodies against Dengue virus in Thailand. | PLoS One | 2026 | 41729959 | PubTator, text mining | PubMed |
| Unbiased cleavage site prediction uncovers viral antagonism of host innate immunity by SARS-CoV-2 3C-like protease. | JCI Insight | 2026 | 41729072 | PubTator, text mining | PubMed |
| Zika virus and host protein interactions for understanding molecular mechanisms of pathogenesis and therapeutic development. | Front Cell Infect Microbiol | 2026 | 41716461 | PubTator, text mining | PubMed |
| Targeted RNA Degradation by RIBOTACs: A Novel Therapeutic Avenue for Ophthalmic Diseases. | Int J Mol Sci | 2026 | 41683912 | PubTator, text mining | PubMed |
| Profound alterations of cancer transcriptomes by the RNase L inhibitor ABCE1 through the modulation of UU/UA-dinucleotide rich transcript abundance. | RNA Biol | 2026 | 41663214 | PubTator, text mining | PubMed |
| From Serendipity to Strategy: Rationalizing Molecular Glue Discovery and Proximity-Induced Pharmacology through Chemical Biology. | J Am Chem Soc | 2026 | 41622634 | PubTator, text mining | PubMed |
| PRRSV Nsp11 antagonizes host antiviral immune response by reducing OAS1 and RNase L expressions. | BMC Vet Res | 2026 | 41618367 | PubTator, text mining | PubMed |
| Deciphering the regulatory landscape of enhancer RNAs in health and disease. | Signal Transduct Target Ther | 2026 | 41605892 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6041/papers?page=3